Human protein phosphatase 2C

US7029897B2 · kind B2 · utility

Assignee

• Incyte Corporation · US

Inventors

• Henry Yue · Sunnyvale, US
• Li Ding · Creve Coeur, US
• Preeti Lal · Sunnyvale, US
• Jennifer Griffin · Fremont, US
• Rajagopal Gururajan · San Jose, US
• Mariah Baughn · San Jose, US
• Craig Ison · San Jose, US
• Jayalaxmi Ramkumar · Fremont, US
• Catherine Tribouley · San Francisco, US
• Anita Swarnakar · San Francisco, US
• Neil Burford · Durham, US
• Olga Bandman · Mountain View, US
• Michael Thornton · Oakland, US
• Farrah Khan · Des Plaines, US
• Narinder Chawla · Union City, US
• Danniel Nguyen · San Jose, US
• Vicki Elliott · San Jose, US
• Yuming Xu · Mountain View, US
• Yan Lu · Mountain View, US
• April Hafalia · Pacifica, US
• Monique Yao · Mountain View, US
• Ameena Gandhi · San Francisco, US
• Chandra Arvizu · San Diego, US
• Ian Forsythe · Edmonton, CA

Key dates

• Filing date: Dec 4, 2001
• Grant date: Apr 18, 2006
• Expiry date: Dec 12, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N9/16
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.